Diabetes and the brain: oxidative stress, inflammation, and autophagy.

Muriach M, Flores-Bellver M, Romero FJ, Barcia JM. · 2014

Read Diabetes and the brain: oxidative stress, inflammation, and autophagy. by Muriach M, Flores-Bellver M, Romero FJ, Barcia JM. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4158559.txt.

Introduction

María Muriach, Miguel Flores-Bellver, Francisco J. Romero, and Jorge M. Barcia reviewed how diabetes harms the brain. Their review came out in Oxidative Medicine and Cellular Longevity in 2014. Diabetes brings mild to fair faults of thought, with slow work pace and stiff thought, much like a brain that ages too fast.

One master switch for swelling, NF-kB, stands where oxygen stress and swelling cross, and it can sense both. Swelling tied to fuel use also sets off stress in the cell's power hubs and in its folding shop. It breaks the self-cleaning that clears worn parts. Blocked cleaning then feeds the swelling path by way of the same switch. The team uses this web to show how a whole-body fuel ill can age the brain in a quiet way.

Catalog record

CREATORMuriach M, Flores-Bellver M, Romero FJ, Barcia JM.
YEAR2014
COLLECTIONPAPERS
FORMATTXT
FILE SIZE49 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4158559

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Diabetes and the Brain: Oxidative Stress, Inflammation, and Autophagy By María Muriach, Miguel Flores-Bellver, Francisco J Romero, Jorge M Barcia Published in: Oxidative Medicine and Cellular Longevity DOI: 10.1155/2014/102158 ABSTRACT Abstract Diabetes mellitus is a common metabolic disorder associated with chronic complications including a state of mild to moderate cognitive impairment, in particular psychomotor slowing and reduced mental flexibility, not attributable to other causes, and shares many symptoms that are best described as accelerated brain ageing. A common theory for aging and for the pathogenesis of this cerebral dysfunctioning in diabetes relates cell death to oxidative stress in strong association to inflammation, and in fact nuclear factor κB (NFκB), a master regulator of inflammation and also a sensor of oxidative stress, has a strategic position at the crossroad between oxidative stress and inflammation. Moreover, metabolic inflammation is, in turn, related to the induction of various intracellular stresses such as mitochondrial oxidative stress, endoplasmic reticulum (ER) stress, and autophagy defect. In parallel, blockade of autophagy can relate to proinflammatory signaling via oxidative stress pathway and NFκB-mediated inflammation. 1. INTRODUCTION Diabetes mellitus is a common metabolic disorder which is associated with chronic complications such as nephropathy, angiopathy, retinopathy, and peripheral neuropathy. However, as early as 1922 it was recognised that diabetes also can lead to cognitive dysfunction [1]. Since then, studies in experimental models and in patients observed alterations in neurotransmission, electrophysiological and structural abnormalities, and neurobehavioral alterations, in particular cognitive dysfunction and increased risk of depression [2]. Moreover, the observed cerebral manifestations of diabetes appear to develop insidiously, largely independent of diabetes-associated acute metabolic and vascular disturbances (such as severe hypo- and hyperglycemic episodes and stroke). Although the magnitude of these cognitive deficits appears to be mild to moderate, they can significantly hamper daily functioning, adversely affecting quality of life [3]. In spite of this, the concept of central neuropathy has been controversial for more than 80 years now, but while trying to describe cognitive impairment in diabetes as a complication of the disease, the term “diabetic encephalopathy” was introduced in 1950 [4]. However, this term “encephalopathy” has not been widely accepted, probably among other reasons, because it does not seem to match with the mild cognitive problems usually seen in (nondemented) diabetic patients. More recently it has been suggested that the term “diabetes-associated cognitive decline” (DACD) describes a state of mild to moderate cognitive impairment, in particular psychomotor slowing and reduced mental flexibility, not attributable to other causes [5]. In addition, it is now clear that diabetes increases the risk of Alzheimer's disease, vascular dementia, and any other type of dementia [6, 7]. 2. PATHOPHYSIOLOGICAL MECHANISMS INVOLVED IN BRAIN DAMAGE IN DIABETES Long-term effects of diabetes on the brain are manifested at structural, neurophysiological, and neuropsychological level, and multiple pathogenic factors appear to be involved in the pathogenesis of the cerebral dysfunctioning in diabetes, such as the hypoglycemic episodes, cerebrovascular alterations, the role of insulin in the brain, and the mechanisms of hyperglycemia induced damage [8]. Moreover, the emerging view is that the diabetic brain features many symptoms that are best described as accelerated brain ageing [9]. A common theory, for aging and for the pathogenesis of this cerebral dysfunctioning in diabetes, relates cell death to oxidative stress mediated by free radicals [10]. Thus, hyperglycemia reduces antioxidant levels and concomitantly increases the production of free radicals. These effects contribute to tissue damage in diabetes mellitus, leading to alterations in the redox potential of the cell with subsequent activation of redox-sensitive genes [11]. The brain is especially vulnerable to oxidative damage as a result of its high oxygen consumption rate, abundant lipid content, and relative paucity of antioxidant enzymes as compared to other tissues. Neuronal cells are particularly sensitive to oxidative insults, and therefore reactive oxygen species (ROS) are involved in many neurodegenerative processes such as diabetes [12–14]. Although under normal physiological conditions a balance exists between the production of ROS and the antioxidant mechanisms, it has been shown that in aging tissues oxidative stress increases due to, among others, decreased activity of antioxidant enzymes [15]. Earlier work and ample evidence have shown that peroxidative damage to lipid and protein occurs with the aging process and the products of these reactions accumulate in the brain with age [16–19]. Similarly, the activities of superoxide dismutase and catalase or glutathione peroxidase enzymes, involved in the antioxidant defense of the diabetic brain, are decreased [20–23]. However, the possible source of oxidative stress in brain injury also includes autoxidation of glucose, lipid peroxidation, and decreased tissue concentrations of low molecular weight antioxidants such as reduced glutathione (GSH) [24–27]. This alteration of glutathione levels may be related to an increased polyol pathway [28] activity as this leads to a depletion of NADPH which is necessary for the enzymatic reduction of oxidized glutathione. Moreover, in these pathological conditions, cellular stress triggers mitochondrial oxidative damage, which may result in apoptosis and/or necrosis [29], and apoptosis induced by oxidative stress has been related to neurogenesis inhibition [30]. Thus, it has been described that DM leads to alterations in the mitochondrial electron transport chain; ROS formation, mitochondrial energy metabolism dysfunction, and oxidative stress are thus being recognized as the main players in diabetes-related complications [31]. In this sense, Cardoso et al. have shown that hippocampal mitochondria of streptozotocin (STZ)-induced diabetic rats presented higher levels of MDA together with an increased glutathione disulfide reductase activity and lower manganese superoxide dismutase (MnSOD) activity and glutathione-to-glutathione disulfide (GSH/GSSG) ratio. It also showed impaired oxidative phosphorylation system characterized by a decreased mitochondrial energization potential and ATP levels and higher repolarization lag phase [32]. On the other hand, although insulin is best known for its involvement in the regulation of glucose metabolism in peripheral tissues, this hormone also affects numerous brain functions including cognition, memory, and synaptic plasticity through complex insulin/insulin receptor (IR) signaling pathways [33]. Therefore, considering the important role of insulin in many aspects of neuronal function in both the peripheral nervous system and the central nervous system, it is possible that perturbation of insulin signaling (both insulin deficiency in T1 diabetes and hyperinsulinemia in T2 diabetes) is in the pathogenesis of neurological diseases [34] and results in neurodegeneration. Until recently, the study of insulin resistance was mainly focused on metabolic tissues such as muscle and adipose tissue; recent data, however, suggest that insulin resistance also develops in the nervous system. Although neurons are not insulin-dependent, they are insulin-responsive [35]. Insulin receptors are widely expressed in the brain, including the olfactory bulb, cerebral cortex, hippocampus, hypothalamus, and amygdala. Insulin resistance in sensory neurons makes cells respond inappropriately to growth factor signals, and this impairment may contribute to the development of neurodegeneration and subsequent diabetic neuropathy. Moreover, insulin regulates mitochondrial metabolism and oxidative capacity through PI3K/Akt signaling [36, 37]; therefore, decreased Akt signaling by hyperinsulinemia- mediated IR may have profound effects on mitochondrial function in neurons and result in subsequent increased oxidative stress [38]. In fact, two of the leading theories that have emerged to explain insulin resistance center on mitochondrial function/dysfunction, although interestingly with opposite views. In one theory, inherited or acquired mitochondrial dysfunction is thought to cause an accumulation of intramyocellular lipids that lead to insulin resistance and implies that strategies to

Read the complete text